Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Vera Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 4 Lin Celia (Chief Medical Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 1,490 shares @ $16.6547, valued at $24.8k
08/23/2023 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 1,490 shares @ $16.6558, valued at $24.8k
08/23/2023 4 Fordyce Marshall (President and CEO) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 5,210 shares @ $16.6562, valued at $86.8k
07/06/2023 4 Young Joseph R (SVP, Finance, Chief Acct Offcr) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Exercised 10,000 options to buy @ $3.9396, valued at $39.4k
05/12/2023 4 SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $7.7, valued at $154k
05/12/2023 4 MORRISSEY MICHAEL (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $7.7, valued at $154k
05/12/2023 4 Morrison Scott W (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $7.7, valued at $154k
05/12/2023 4 Katabi Maha (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $7.7, valued at $154k
05/12/2023 4 Hall Kimball (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $7.7, valued at $154k
05/12/2023 4 ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $7.7, valued at $154k
04/03/2023 4 SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 2,300 shares @ $7.2395, valued at $16.7k
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/21/2023 4 SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 74,045 shares @ $7.1157, valued at $526.9k
Bought 15,252 shares @ $7.2143, valued at $110k
03/17/2023 4 SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 32,844 shares @ $7.1249, valued at $234k
Bought 60,097 shares @ $7.093, valued at $426.3k
03/07/2023 4 SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 1,000 shares @ $7.245, valued at $7.2k
02/27/2023 4 SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 200 shares @ $7.235, valued at $1.4k
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2023 4 SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 46,163 shares @ $7.24, valued at $334.2k
Bought 131,602 shares @ $7.03, valued at $925.2k
Bought 87,956 shares @ $7.08, valued at $622.7k
Bought 45,357 shares @ $7.22, valued at $327.5k
02/08/2023 4 Longitude Capital Partners IV, LLC (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 1,714,285 shares @ $7, valued at $12M
02/08/2023 4 ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 1,714,285 shares @ $7, valued at $12M
02/08/2023 3 Longitude Prime Partners, LLC (10% Owner) has filed a Form 3 on Vera Therapeutics, Inc.
02/08/2023 4 Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 285,714 shares @ $7, valued at $2M
02/08/2023 4 Young Joseph R (SVP, Finance, Chief Acct Offcr) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 5,714 shares @ $7, valued at $40k
02/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 6,900 shares @ $18.2498, valued at $125.9k
Sold 11,733 shares @ $18.2767, valued at $214.4k
Sold 1,078 shares @ $18.19, valued at $19.6k
Exercised 6,900 options to buy @ $11, valued at $75.9k
Exercised 11,733 options to buy @ $11, valued at $129.1k
Exercised 1,078 options to buy @ $6.3728, valued at $6.9k
12/08/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 494 shares @ $16.47, valued at $8.1k
11/21/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 1,078 shares @ $15.8606, valued at $17.1k
Sold 2,211 shares @ $15.8436, valued at $35k
Exercised 1,078 options to buy @ $6.3728, valued at $6.9k
Exercised 2,211 options to buy @ $2.8968, valued at $6.4k
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2022 4 Fordyce Marshall (President and CEO) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 11,369 shares @ $20.385, valued at $231.8k
Sold 2,408 shares @ $21.159, valued at $51k
Sold 6,899 shares @ $20.2886, valued at $140k
Sold 10,418 shares @ $21.6926, valued at $226k
Sold 906 shares @ $22.1863, valued at $20.1k
Exercised 13,777 options to buy @ $2.8968, valued at $39.9k
Exercised 18,223 options to buy @ $2.8968, valued at $52.8k
09/22/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 978 shares @ $20.5442, valued at $20.1k
Sold 100 shares @ $21, valued at $2.1k
Sold 1,828 shares @ $20.4757, valued at $37.4k
Sold 334 shares @ $20.9153, valued at $7k
Sold 2,314 shares @ $20.241, valued at $46.8k
Sold 10,112 shares @ $20.8045, valued at $210.4k
Sold 910 shares @ $21.1255, valued at $19.2k
Sold 264 shares @ $22.3465, valued at $5.9k
Exercised 1,078 options to buy @ $6.3728, valued at $6.9k
Exercised 2,162 options to buy @ $2.8968, valued at $6.3k
Exercised 12,426 options to buy @ $11, valued at $136.7k
09/14/2022 4 Fordyce Marshall (President and CEO) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 10,163 shares @ $20.784, valued at $211.2k
Sold 12,200 shares @ $21.4761, valued at $262k
Exercised 22,363 options to buy @ $2.8968, valued at $64.8k
09/13/2022 4/A Fordyce Marshall (President and CEO) has filed a Form 4 on Vera Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy